Budesonide MMX® for the induction of remission of mild to moderate ulcerative colitis: a pooled safety analysis.

समान संसाधन

• Induction of clinical and colonoscopic remission of mild-to-moderate ulcerative colitis with budesonide MMX 9 mg: pooled analysis of two phase 3 studies.
  द्वारा: Sandborn, W, और अन्य
  प्रकाशित: (2015)
• Induction of Clinical and Endoscopic Remission of Mild to Moderately Active Ulcerative Colitis With Budesonide MMX (R) 9 mg: Analysis of Pooled Data from Two Phase 3 Studies
  द्वारा: Sandborn, W, और अन्य
  प्रकाशित: (2011)
• Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study.
  द्वारा: Travis, S, और अन्य
  प्रकाशित: (2014)
• Once-daily budesonide MMX® extended-release tablets induce remission in patients with mild to moderate ulcerative colitis: results from the CORE I study.
  द्वारा: Sandborn, W, और अन्य
  प्रकाशित: (2012)
• Budesonide MMX in the Treatment of Ulcerative Colitis: Current Perspectives on Efficacy and Safety
  द्वारा: Maconi G, और अन्य
  प्रकाशित: (2021-04-01)